Studies have shown that PPAR-α activators modulate obesity in rodents via increasing hepatic fatty acid oxidation and decreasing circulating triglyceride levels [68–70]. This evidence concerns the gene PPARA and obesity due to melanocortin 4 receptor deficiency.